Rhythm Pharmaceuticals, Inc. (RYTM) compared with its closest peers (MRVI, STOK, CYRX, PHAT, SNDX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Maravai LifeSciences, Stoke Therapeutics, Cryoport, Phathom Pharmaceuticals, Syndax Pharmaceuticals, Vanda Pharmaceuticals, IDEAYA Biosciences, Puma Biotechnology, LifeVantage and Heron Therapeutics share Rhythm Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Maravai LifeSciences Holdings, Inc. (MRVI) | $1.28B | -3.6 |
| Stoke Therapeutics, Inc. (STOK) | $2.01B | -264.3 |
| Cryoport, Inc. (CYRX) | $866.86M | 6.9 |
| Phathom Pharmaceuticals, Inc. (PHAT) | $718.00M | -5.5 |
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.74B | -6.4 |
| Vanda Pharmaceuticals Inc. (VNDA) | $318.12M | -2.4 |
| IDEAYA Biosciences, Inc. (IDYA) | $3.83B | -27.0 |
| Puma Biotechnology, Inc. (PBYI) | $476.97M | 17.9 |
| LifeVantage Corporation (LFVN) | $84.02M | 11.6 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
RYTM overview · RYTM earnings · RYTM financials · RYTM KPIs · RYTM documents · RYTM ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.